Atlas Trials

Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)

Clinical trial NCT01775488 · WITHDRAWN

Trial details

NCT number
NCT01775488
Sponsor
HistoSonics, Inc.
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Benign Prostatic Hyperplasia (BPH)
Start date
2013-06-01
Primary completion
2014-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.